S-Space

Browse

Author

Showing results 1 to 2 of 2

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2020-05	Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study Abou-Alfa, Ghassan K.; Sahai, Vaibhav; Hollebecque, Antoine; Vaccaro, Gina; Melisi, Davide; Al-Rajabi, Raed; Paulson, Andrew S.; Borad, Mitesh J.; Gallinson, David; Murphy, Adrian G.; Oh, Do-Youn; Dotan, Efrat; Catenacci, Daniel, V; Van Cutsem, Eric; Ji, Tao; Lihou, Christine F.; Zhen, Huiling; Feliz, Luis; Vogel, Arndt The Lancet Oncology, Vol.21 No.5, pp.671-684	DOI
2021	Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer Melisi, Davide; Oh, Do-Youn; Hollebecque, Antoine; Calvo, Emiliano; Varghese, Anna; Borazanci, Erkut; Macarulla, Teresa; Merz, Valeria; Zecchetto, Camilla; Zhao, Yumin; Gueorguieva, Ivelina; Man, Michael; Gandhi, Leena; Estrem, Shawn T.; Benhadji, Karim A.; Lanasa, Mark C.; Avsar, Emin; Guba, Susan C.; Garcia-Carbonero, Rocio Journal for ImmunoTherapy of Cancer, Vol.9 No.3, p. e002068	DOI